Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice
about
Cutaneous immunization: an evolving paradigm in influenza vaccinesMolecular mechanisms for enhanced DNA vaccine immunogenicity.The contribution of vaccination to global health: past, present and future.Micro-fractional epidermal powder delivery for improved skin vaccinationPercutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored VaccinesInactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses.Potent response of QS-21 as a vaccine adjuvant in the skin when delivered with the Nanopatch, resulted in adjuvant dose sparing.Microneedles: an innovative platform for gene delivery.Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.Mucosal vaccine delivery: Current state and a pediatric perspectiveDevelopment of replication-deficient adenovirus malaria vaccines.Microfabrication for Drug DeliveryHigh-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses.Long-lived tissue resident HIV-1 specific memory CD8+ T cells are generated by skin immunization with live virus vectored microneedle arrays.Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the NanopatchTM Microprojection Array.A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques.
P2860
Q30358895-7F57A78F-045C-434E-A08E-7BEEFF066DD8Q30366743-9FAB312A-A3C0-4BF6-B395-CF9AAE73235BQ33624593-BC189028-6364-4EA4-AEC5-E6F4851227D1Q34229340-862F633C-487F-4C5A-B3BB-DCDD2C42F8BFQ35928588-37EC3419-CFB3-4539-BB76-34AA9B09A9F4Q36616041-FBE49394-BDCA-4ECB-B58C-D0A0B82617B1Q37087055-30F0C10B-D976-4D3A-9775-34AC9FEF6256Q38539948-A66DF8F4-77B4-4246-828E-AD7ACE696CE2Q38630763-0DE11901-4A1A-47EE-ADB5-219CC3F137B1Q38727453-8B735B41-9505-4294-A6C2-568B637CA51DQ38949194-849AC92A-C616-4A57-9A9B-5B13586C67C5Q41006286-E8DCD878-4170-439D-8191-606725DC1549Q41925081-4A4DC793-AA1C-46E0-8D38-23AA7115AF0DQ45325894-9A45F896-098D-4F39-BC0D-6F379D853AA0Q47607706-CC60113E-84B6-4E81-BB45-F19860E34D3EQ48505959-07A6ECF7-ABB1-49B4-ADB7-D425E96D90B1Q52559076-194A0F78-D9FD-444A-A015-A79D0537D269
P2860
Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dry-coated live viral vector v ...... cific T cell responses in mice
@en
type
label
Dry-coated live viral vector v ...... cific T cell responses in mice
@en
prefLabel
Dry-coated live viral vector v ...... cific T cell responses in mice
@en
P2093
P2860
P50
P1433
P1476
Dry-coated live viral vector v ...... cific T cell responses in mice
@en
P2093
Celia L McNeilly
Clare A Primiero
Germain J P Fernando
Mark A F Kendall
Sally R Yukiko
P2860
P304
P356
10.1371/JOURNAL.PONE.0067888
P407
P577
2013-07-09T00:00:00Z